Skip to main content
NCBI home page
CMAJ : Canadian Medical Association Journal logoLink to CMAJ : Canadian Medical Association Journal
. 1996 Jul 1;155(1):25–37.

Guidelines for the emergency management of asthma in adults. CAEP/CTS Asthma Advisory Committee. Canadian Association of Emergency Physicians and the Canadian Thoracic Society.

R C Beveridge 1, A F Grunfeld 1, R V Hodder 1, P R Verbeek 1
PMCID: PMC1487869  PMID: 8673983

Abstract

OBJECTIVE: To develop a set of comprehensive, standardized evidence-based guidelines for the assessment and treatment of acute asthma in adults in the emergency setting. OPTIONS: The use of medications was evaluated by class, dose, route, onset of action and optimal mode of delivery. The use of objective measurements and clinical features to assess response to therapy were evaluated in relation to the decision to admit or discharge the patient or arrange for follow-up care. OUTCOMES: Control of symptoms and disease reflected in hospital admission rates, frequency of treatment failures following discharge, resolution of symptoms and improvement of spirometric test results. EVIDENCE: Previous guidelines, articles retrieved through a search of MEDLINE, emergency medical abstracts and information from members of the expert panel were reviewed by members of the Canadian Association of Emergency Physicians (CAEP) and the Canadian Thoracic Society. Where evidence was not available, consensus was reached by the expert panel. The resulting guidelines were reviewed by members of the parent organizations. VALUES: The evidence-based methods and values of the Canadian Task Force on the Periodic Health Examination were used. BENEFITS, HARMS AND COSTS: As many as 80% of the approximate 400 deaths from asthma each year in Canada are felt to be preventable. The use of guidelines, aggressive emergency management and consistent use of available options at discharge are expected to decrease the rates of unnecessary hospital admissions and return visits to emergency departments because of treatment failures. Substantial decreases in costs are expected from the use of less expensive drugs, or drug delivery systems, fewer hospital admissions and earlier return to full activity after discharge. RECOMMENDATIONS: Beta2-agonists are the first-line therapy for the management of acute asthma in the emergency department (grade A recommendation). Bronchodilators should be administered by the inhaled route and titrated using objective and clinical measures of airflow limitation (grade A). Metered-dose inhalers are preferred to wet nebulizers, and a chamber (spacer device) is recommended for severe asthma (grade A). Anticholinergic therapy should be added to beta 2 agonist therapy in severe and life-threatening cases and may be considered in cases of mild to moderate asthma (grade A). Aminophylline is not recommended for use in the first 4 hours of therapy (grade A). Ketamine and succinylcholine are recommended for rapid sequence intubation in life-threatening cases (grade B). Adrenaline (administered subcutaneously or intravenously), salbutamol (administered intravenously) and anesthetics (inhaled) are recommended as alternatives to conventional therapy in unresponsive life-threatening cases (grade B). Severity of airflow limitation should be determined according to the forced expiratory volume at 1 second or the peak expiratory flow rate, or both, before and after treatment and at discharge (grade A). Consideration for discharge should be based on both spirometric test results and assessment of clinical risk factors for relapse (grade A). All patients should be considered candidates for systemic corticosteroid therapy at discharge (grade A). Those requiring corticosteroid therapy should be given 30 to 60 mg of prednisone orally (or equivalent) per day for 7 to 14 days; no tapering is required (grade A). Inhaled corticosteroids are an integral component of therapy and should be prescribed for all patients receiving oral corticosteroid therapy at discharge (grade A). Patients should be given a discharge treatment plan and clear instructions for follow-up care (grade C). VALIDATION: The guidelines share the same principles of those from the British Thoracic Society and the National Institutes of Health. Two specific validation initiatives have been undertaken: (a) several Canadian centres have been involved in the collection of comprehensive administrative data to assess compliance and outcome measures and (b) a survey of Canadian emergency physicians conducted to gather baseline informaton of treatment patterns, was conducted before development of the guidelines and will be repeated to re-evaluate emergency management of asthma.

Full text

PDF
25

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bailey W. C., Richards J. M., Jr, Brooks C. M., Soong S. J., Windsor R. A., Manzella B. A. A randomized trial to improve self-management practices of adults with asthma. Arch Intern Med. 1990 Aug;150(8):1664–1668. [PubMed] [Google Scholar]
  2. Banner A. S., Shah R. S., Addington W. W. Rapid prediction of need for hospitalization in acute asthma. JAMA. 1976 Mar 29;235(13):1337–1338. [PubMed] [Google Scholar]
  3. Barnes P. J. Poorly perceived asthma. Thorax. 1992 Jun;47(6):408–409. doi: 10.1136/thx.47.6.408. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Baumann U. A., Haerdi E., Keller R. Relations between clinical signs and lung function in bronchial asthma: how is acute bronchial obstruction reflected in dyspnoea and wheezing? Respiration. 1986;50(4):294–300. doi: 10.1159/000194941. [DOI] [PubMed] [Google Scholar]
  5. Beasley C. R., O'Donnell T. V. Pear shaped spacer nebuhaler compared with nebulised solution for terbutaline administration in acute severe asthma. N Z Med J. 1985 Oct 9;98(788):854–855. [PubMed] [Google Scholar]
  6. Becker A. B., Nelson N. A., Simons F. E. Inhaled salbutamol (albuterol) vs injected epinephrine in the treatment of acute asthma in children. J Pediatr. 1983 Mar;102(3):465–469. doi: 10.1016/s0022-3476(83)80679-9. [DOI] [PubMed] [Google Scholar]
  7. Benatar S. R. Fatal asthma. N Engl J Med. 1986 Feb 13;314(7):423–429. doi: 10.1056/NEJM198602133140706. [DOI] [PubMed] [Google Scholar]
  8. Benton G., Thomas R. C., Nickerson B. G., McQuitty J. C., Okikawa J. Experience with a metered-dose inhaler with a spacer in the pediatric emergency department. Am J Dis Child. 1989 Jun;143(6):678–681. doi: 10.1001/archpedi.1989.02150180056020. [DOI] [PubMed] [Google Scholar]
  9. Betts E. K., Parkin C. E. Use of ketamine in an asthmatic child: a case report. Anesth Analg. 1971 May-Jun;50(3):420–421. [PubMed] [Google Scholar]
  10. Bierman M. I., Brown M., Muren O., Keenan R. L., Glauser F. L. Prolonged isoflurane anesthesia in status asthmaticus. Crit Care Med. 1986 Sep;14(9):832–833. doi: 10.1097/00003246-198609000-00017. [DOI] [PubMed] [Google Scholar]
  11. Bloomfield P., Carmichael J., Petrie G. R., Jewell N. P., Crompton G. K. Comparison of salbutamol given intravenously and by intermittent positive-pressure breathing in life-threatening asthma. Br Med J. 1979 Mar 31;1(6167):848–850. doi: 10.1136/bmj.1.6167.848. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Bowler S. D., Mitchell C. A., Armstrong J. G. Corticosteroids in acute severe asthma: effectiveness of low doses. Thorax. 1992 Aug;47(8):584–587. doi: 10.1136/thx.47.8.584. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Bowton D. L., Goldsmith W. M., Haponik E. F. Substitution of metered-dose inhalers for hand-held nebulizers. Success and cost savings in a large, acute-care hospital. Chest. 1992 Feb;101(2):305–308. doi: 10.1378/chest.101.2.305. [DOI] [PubMed] [Google Scholar]
  14. Britton J., Tattersfield A. Comparison of cumulative and non-cumulative techniques to measure dose-response curves for beta agonists in patients with asthma. Thorax. 1984 Aug;39(8):597–599. doi: 10.1136/thx.39.8.597. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Britton M. G., Collins J. V., Brown D., Fairhurst N. P., Lambert R. G. High-dose corticosteroids in severe acute asthma. Br Med J. 1976 Jul 10;2(6027):73–74. doi: 10.1136/bmj.2.6027.73. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Bryant D. H. Nebulized ipratropium bromide in the treatment of acute asthma. Chest. 1985 Jul;88(1):24–29. doi: 10.1378/chest.88.1.24. [DOI] [PubMed] [Google Scholar]
  17. Bryant D. H., Rogers P. Effects of ipratropium bromide nebulizer solution with and without preservatives in the treatment of acute and stable asthma. Chest. 1992 Sep;102(3):742–747. doi: 10.1378/chest.102.3.742. [DOI] [PubMed] [Google Scholar]
  18. Bucknall C. E., Robertson C., Moran F., Stevenson R. D. Management of asthma in hospital: a prospective audit. Br Med J (Clin Res Ed) 1988 Jun 11;296(6637):1637–1639. doi: 10.1136/bmj.296.6637.1637. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Burr M. L., Butland B. K., King S., Vaughan-Williams E. Changes in asthma prevalence: two surveys 15 years apart. Arch Dis Child. 1989 Oct;64(10):1452–1456. doi: 10.1136/adc.64.10.1452. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Carden D. L., Nowak R. M., Sarkar D., Tomlanovich M. C. Vital signs including pulsus paradoxus in the assessment of acute bronchial asthma. Ann Emerg Med. 1983 Feb;12(2):80–83. doi: 10.1016/s0196-0644(83)80377-1. [DOI] [PubMed] [Google Scholar]
  21. Cayton R. M., Webber B., Paterson J. W., Clark T. J. A comparison of salbutamol given by pressure-packed aerosol or nebulization via IPPB in acute asthma. Br J Dis Chest. 1978 Jul;72(3):222–224. doi: 10.1016/0007-0971(78)90045-1. [DOI] [PubMed] [Google Scholar]
  22. Chapman K. R., Verbeek P. R., White J. G., Rebuck A. S. Effect of a short course of prednisone in the prevention of early relapse after the emergency room treatment of acute asthma. N Engl J Med. 1991 Mar 21;324(12):788–794. doi: 10.1056/NEJM199103213241202. [DOI] [PubMed] [Google Scholar]
  23. Charlton I., Charlton G., Broomfield J., Mullee M. A. Evaluation of peak flow and symptoms only self management plans for control of asthma in general practice. BMJ. 1990 Dec 15;301(6765):1355–1359. doi: 10.1136/bmj.301.6765.1355. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Cheong B., Reynolds S. R., Rajan G., Ward M. J. Intravenous beta agonist in severe acute asthma. BMJ. 1988 Aug 13;297(6646):448–450. doi: 10.1136/bmj.297.6646.448. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Chidley K. E., Wood-Baker R., Town G. I., Sleet R. A., Holgate S. T. Reassessment of asthma management in an accident and emergency department. Respir Med. 1991 Sep;85(5):373–377. doi: 10.1016/s0954-6111(06)80180-0. [DOI] [PubMed] [Google Scholar]
  26. Clark N. M. Asthma self-management education. Research and implications for clinical practice. Chest. 1989 May;95(5):1110–1113. doi: 10.1378/chest.95.5.1110. [DOI] [PubMed] [Google Scholar]
  27. Colacone A., Afilalo M., Wolkove N., Kreisman H. A comparison of albuterol administered by metered dose inhaler (and holding chamber) or wet nebulizer in acute asthma. Chest. 1993 Sep;104(3):835–841. doi: 10.1378/chest.104.3.835. [DOI] [PubMed] [Google Scholar]
  28. Colacone A., Wolkove N., Stern E., Afilalo M., Rosenthal T. M., Kreisman H. Continuous nebulization of albuterol (salbutamol) in acute asthma. Chest. 1990 Mar;97(3):693–697. doi: 10.1378/chest.97.3.693. [DOI] [PubMed] [Google Scholar]
  29. Coleridge J., Cameron P., Epstein J., Teichtahl H. Intravenous aminophylline confers no benefit in acute asthma treated with intravenous steroids and inhaled bronchodilators. Aust N Z J Med. 1993 Aug;23(4):348–354. doi: 10.1111/j.1445-5994.1993.tb01434.x. [DOI] [PubMed] [Google Scholar]
  30. Corbridge T. C., Hall J. B. The assessment and management of adults with status asthmaticus. Am J Respir Crit Care Med. 1995 May;151(5):1296–1316. doi: 10.1164/ajrccm.151.5.7735578. [DOI] [PubMed] [Google Scholar]
  31. Corre K. A., Rothstein R. J. Assessing severity of adult asthma and need for hospitalization. Ann Emerg Med. 1985 Jan;14(1):45–52. doi: 10.1016/s0196-0644(85)80735-6. [DOI] [PubMed] [Google Scholar]
  32. Corssen G., Gutierrez J., Reves J. G., Huber F. C., Jr Ketamine in the anesthetic management of asthmatic patients. Anesth Analg. 1972 Jul-Aug;51(4):588–596. [PubMed] [Google Scholar]
  33. Crane J., Pearce N., Burgess C., Woodman K., Robson B., Beasley R. Markers of risk of asthma death or readmission in the 12 months following a hospital admission for asthma. Int J Epidemiol. 1992 Aug;21(4):737–744. doi: 10.1093/ije/21.4.737. [DOI] [PubMed] [Google Scholar]
  34. Crompton G. K. Nebulized or intravenous beta 2 adrenoceptor agonist therapy in acute asthma? Eur Respir J. 1990 Feb;3(2):125–126. [PubMed] [Google Scholar]
  35. Dales R. E., Kerr P. E., Schweitzer I., Reesor K., Gougeon L., Dickinson G. Asthma management preceding an emergency department visit. Arch Intern Med. 1992 Oct;152(10):2041–2044. [PubMed] [Google Scholar]
  36. Darioli R., Perret C. Mechanical controlled hypoventilation in status asthmaticus. Am Rev Respir Dis. 1984 Mar;129(3):385–387. doi: 10.1164/arrd.1984.129.3.385. [DOI] [PubMed] [Google Scholar]
  37. Ebden P., Carey O. J., Quinton D., Cookson J. B. A study of acute asthma in the accident and emergency department. Br J Dis Chest. 1988 Apr;82(2):162–167. doi: 10.1016/0007-0971(88)90037-x. [DOI] [PubMed] [Google Scholar]
  38. Echeverria M., Gelb A. W., Wexler H. R., Ahmad D., Kenefick P. Enflurane and halothane in status asthmaticus. Chest. 1986 Jan;89(1):152–154. doi: 10.1378/chest.89.1.152. [DOI] [PubMed] [Google Scholar]
  39. Ellul-Micallef R., Fenech F. F. Effect of intravenous prednisolone in asthmatics with diminished adrenergic responsiveness. Lancet. 1975 Dec 27;2(7948):1269–1271. doi: 10.1016/s0140-6736(75)90608-x. [DOI] [PubMed] [Google Scholar]
  40. Engel T., Dirksen A., Frølund L., Heinig J. H., Svendsen U. G., Pedersen B. K., Weeke B. Methylprednisolone pulse therapy in acute severe asthma. A randomized, double-blind study. Allergy. 1990 Apr;45(3):224–230. doi: 10.1111/j.1398-9995.1990.tb00487.x. [DOI] [PubMed] [Google Scholar]
  41. Engel T., Heinig J. H. Glucocorticosteroid therapy in acute severe asthma--a critical review. Eur Respir J. 1991 Jul;4(7):881–889. [PubMed] [Google Scholar]
  42. Ernst P., Habbick B., Suissa S., Hemmelgarn B., Cockcroft D., Buist A. S., Horwitz R. I., McNutt M., Spitzer W. O. Is the association between inhaled beta-agonist use and life-threatening asthma because of confounding by severity? Am Rev Respir Dis. 1993 Jul;148(1):75–79. doi: 10.1164/ajrccm/148.1.75. [DOI] [PubMed] [Google Scholar]
  43. FREEDMAN B. J. Accidental adrenaline overdosage and its treatment with piperoxan. Lancet. 1955 Sep 17;269(6890):575–578. doi: 10.1016/s0140-6736(55)92581-2. [DOI] [PubMed] [Google Scholar]
  44. Fanta C. H., Rossing T. H., McFadden E. R., Jr Emergency room of treatment of asthma. Relationships among therapeutic combinations, severity of obstruction and time course of response. Am J Med. 1982 Mar;72(3):416–422. doi: 10.1016/0002-9343(82)90498-3. [DOI] [PubMed] [Google Scholar]
  45. Fanta C. H., Rossing T. H., McFadden E. R., Jr Glucocorticoids in acute asthma. A critical controlled trial. Am J Med. 1983 May;74(5):845–851. doi: 10.1016/0002-9343(83)91076-8. [DOI] [PubMed] [Google Scholar]
  46. Fanta C. H., Rossing T. H., McFadden E. R., Jr Treatment of acute asthma. Is combination therapy with sympathomimetics and methylxanthines indicated? Am J Med. 1986 Jan;80(1):5–10. doi: 10.1016/0002-9343(86)90041-0. [DOI] [PubMed] [Google Scholar]
  47. Fiel S. B., Swartz M. A., Glanz K., Francis M. E. Efficacy of short-term corticosteroid therapy in outpatient treatment of acute bronchial asthma. Am J Med. 1983 Aug;75(2):259–262. doi: 10.1016/0002-9343(83)91202-0. [DOI] [PubMed] [Google Scholar]
  48. Fischer M. M. Ketamine hydrochloride in severe bronchospasm. Anaesthesia. 1977 Sep;32(8):771–772. doi: 10.1111/j.1365-2044.1977.tb10079.x. [DOI] [PubMed] [Google Scholar]
  49. FitzGerald J. M., Hargreave F. E. The assessment and management of acute life-threatening asthma. Chest. 1989 Apr;95(4):888–894. doi: 10.1378/chest.95.4.888. [DOI] [PubMed] [Google Scholar]
  50. FitzGerald J. M., Swan D., Turner M. O. The role of asthma education. CMAJ. 1992 Sep 15;147(6):855–856. [PMC free article] [PubMed] [Google Scholar]
  51. Fitzgerald J. M., Hargreave F. E. Acute asthma: emergency department management and prospective evaluation of outcome. CMAJ. 1990 Mar 15;142(6):591–595. [PMC free article] [PubMed] [Google Scholar]
  52. Fuglsang G., Pedersen S. Comparison of Nebuhaler and nebulizer treatment of acute severe asthma in children. Eur J Respir Dis. 1986 Aug;69(2):109–113. [PubMed] [Google Scholar]
  53. Garrett J. E., Mulder J., Veale A. Trends in the use of an urban accident and emergency department by asthmatics. N Z Med J. 1988 May 25;101(846):253–255. [PubMed] [Google Scholar]
  54. Gross N. J. The use of anticholinergic agents in the treatment of airways disease. Clin Chest Med. 1988 Dec;9(4):591–598. [PubMed] [Google Scholar]
  55. Hargreave F. E., Dolovich J., Newhouse M. T. The assessment and treatment of asthma: a conference report. J Allergy Clin Immunol. 1990 Jun;85(6):1098–1111. doi: 10.1016/0091-6749(90)90056-a. [DOI] [PubMed] [Google Scholar]
  56. Harrison B. D., Stokes T. C., Hart G. J., Vaughan D. A., Ali N. J., Robinson A. A. Need for intravenous hydrocortisone in addition to oral prednisolone in patients admitted to hospital with severe asthma without ventilatory failure. Lancet. 1986 Jan 25;1(8474):181–184. doi: 10.1016/s0140-6736(86)90654-9. [DOI] [PubMed] [Google Scholar]
  57. Haskell R. J., Wong B. M., Hansen J. E. A double-blind, randomized clinical trial of methylprednisolone in status asthmaticus. Arch Intern Med. 1983 Jul;143(7):1324–1327. [PubMed] [Google Scholar]
  58. Hedges J. R., Dronen S. C., Feero S., Hawkins S., Syverud S. A., Shultz B. Succinylcholine-assisted intubations in prehospital care. Ann Emerg Med. 1988 May;17(5):469–472. doi: 10.1016/s0196-0644(88)80238-5. [DOI] [PubMed] [Google Scholar]
  59. Hemming A., MacKenzie I., Finfer S. Response to ketamine in status asthmaticus resistant to maximal medical treatment. Thorax. 1994 Jan;49(1):90–91. doi: 10.1136/thx.49.1.90. [DOI] [PMC free article] [PubMed] [Google Scholar]
  60. Higgins R. M., Stradling J. R., Lane D. J. Should ipratropium bromide be added to beta-agonists in treatment of acute severe asthma? Chest. 1988 Oct;94(4):718–722. doi: 10.1378/chest.94.4.718. [DOI] [PubMed] [Google Scholar]
  61. Huang D., O'Brien R. G., Harman E., Aull L., Reents S., Visser J., Shieh G., Hendeles L. Does aminophylline benefit adults admitted to the hospital for an acute exacerbation of asthma? Ann Intern Med. 1993 Dec 15;119(12):1155–1160. doi: 10.7326/0003-4819-119-12-199312150-00001. [DOI] [PubMed] [Google Scholar]
  62. Idris A. H., McDermott M. F., Raucci J. C., Morrabel A., McGorray S., Hendeles L. Emergency department treatment of severe asthma. Metered-dose inhaler plus holding chamber is equivalent in effectiveness to nebulizer. Chest. 1993 Mar;103(3):665–672. doi: 10.1378/chest.103.3.665. [DOI] [PubMed] [Google Scholar]
  63. Ikeda K., Nakashima A., Ikeda A., Fujita H., Tsukino M. [A clinical trial to determine whether intravenous aminophylline is indispensable in the treatment of status asthmaticus]. Nihon Kyobu Shikkan Gakkai Zasshi. 1990 Jul;28(7):978–984. [PubMed] [Google Scholar]
  64. Jackson R., Sears M. R., Beaglehole R., Rea H. H. International trends in asthma mortality: 1970 to 1985. Chest. 1988 Nov;94(5):914–918. doi: 10.1378/chest.94.5.914. [DOI] [PubMed] [Google Scholar]
  65. Jasper A. C., Mohsenifar Z., Kahan S., Goldberg H. S., Koerner S. K. Cost-benefit comparison of aerosol bronchodilator delivery methods in hospitalized patients. Chest. 1987 Apr;91(4):614–618. doi: 10.1378/chest.91.4.614. [DOI] [PubMed] [Google Scholar]
  66. Johnson A. J., Nunn A. J., Somner A. R., Stableforth D. E., Stewart C. J. Circumstances of death from asthma. Br Med J (Clin Res Ed) 1984 Jun 23;288(6434):1870–1872. doi: 10.1136/bmj.288.6434.1870. [DOI] [PMC free article] [PubMed] [Google Scholar]
  67. Johnston R. G., Noseworthy T. W., Friesen E. G., Yule H. A., Shustack A. Isoflurane therapy for status asthmaticus in children and adults. Chest. 1990 Mar;97(3):698–701. doi: 10.1378/chest.97.3.698. [DOI] [PubMed] [Google Scholar]
  68. Josephson G. W., MacKenzie E. J., Lietman P. S., Gibson G. Emergency treatment of asthma. A comparison of two treatment regimens. JAMA. 1979 Aug 17;242(7):639–643. [PubMed] [Google Scholar]
  69. Jónsson S., Kjartansson G., Gíslason D., Helgason H. Comparison of the oral and intravenous routes for treating asthma with methylprednisolone and theophylline. Chest. 1988 Oct;94(4):723–726. doi: 10.1378/chest.94.4.723. [DOI] [PubMed] [Google Scholar]
  70. Kelly H. W., Murphy S. Should we stop using theophylline for the treatment of the hospitalized patient with status asthmaticus? DICP. 1989 Dec;23(12):995–998. doi: 10.1177/106002808902301209. [DOI] [PubMed] [Google Scholar]
  71. Kelsen S. G., Kelsen D. P., Fleeger B. F., Jones R. C., Rodman T. Emergency room assessment and treatment of patients with acute asthma. Adequacy of the conventional approach. Am J Med. 1978 Apr;64(4):622–628. doi: 10.1016/0002-9343(78)90582-x. [DOI] [PubMed] [Google Scholar]
  72. Kuo E., Kesten S. A retrospective comparative study of in-hospital management of acute severe asthma: 1984 vs 1989. Chest. 1993 Jun;103(6):1655–1661. doi: 10.1378/chest.103.6.1655. [DOI] [PubMed] [Google Scholar]
  73. L'Hommedieu C. S., Arens J. J. The use of ketamine for the emergency intubation of patients with status asthmaticus. Ann Emerg Med. 1987 May;16(5):568–571. doi: 10.1016/s0196-0644(87)80688-1. [DOI] [PubMed] [Google Scholar]
  74. Leahy B. C., Gomm S. A., Allen S. C. Comparison of nebulized salbutamol with nebulized ipratropium bromide in acute asthma. Br J Dis Chest. 1983 Apr;77(2):159–163. doi: 10.1016/0007-0971(83)90022-0. [DOI] [PubMed] [Google Scholar]
  75. Littenberg B. Aminophylline treatment in severe, acute asthma. A meta-analysis. JAMA. 1988 Mar 18;259(11):1678–1684. [PubMed] [Google Scholar]
  76. Littenberg B., Gluck E. H. A controlled trial of methylprednisolone in the emergency treatment of acute asthma. N Engl J Med. 1986 Jan 16;314(3):150–152. doi: 10.1056/NEJM198601163140304. [DOI] [PubMed] [Google Scholar]
  77. Louw S. J., Goldin J. G., Isaacs S. Relative efficacy of nebulised ipratropium bromide and fenoterol in acute severe asthma. S Afr Med J. 1990 Jan 6;77(1):24–26. [PubMed] [Google Scholar]
  78. Mao Y., Semenciw R., Morrison H., MacWilliam L., Davies J., Wigle D. Increased rates of illness and death from asthma in Canada. CMAJ. 1987 Oct 1;137(7):620–624. [PMC free article] [PubMed] [Google Scholar]
  79. May C. S., Paterson J. W., Spiro S. G., Johnson A. J. Effect of intravenous injection of salbutamol in asthma. Br J Clin Pharmacol. 1975 Dec;2(6):495–501. doi: 10.1111/j.1365-2125.1975.tb00566.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  80. Mayo P. H., Richman J., Harris H. W. Results of a program to reduce admissions for adult asthma. Ann Intern Med. 1990 Jun 1;112(11):864–871. doi: 10.7326/0003-4819-112-11-864. [DOI] [PubMed] [Google Scholar]
  81. McFadden E. R., Jr Critical appraisal of the therapy of asthma--an idea whose time has come. Am Rev Respir Dis. 1986 May;133(5):723–724. doi: 10.1164/arrd.1986.133.5.723. [DOI] [PubMed] [Google Scholar]
  82. McFadden E. R., Jr Dosages of corticosteroids in asthma. Am Rev Respir Dis. 1993 May;147(5):1306–1310. doi: 10.1164/ajrccm/147.5.1306. [DOI] [PubMed] [Google Scholar]
  83. McFadden E. R., Jr, Kiser R., DeGroot W. J. Acute bronchial asthma. Relations between clinical and physiologic manifestations. N Engl J Med. 1973 Feb 1;288(5):221–225. doi: 10.1056/NEJM197302012880501. [DOI] [PubMed] [Google Scholar]
  84. McFadden E. R., Jr, Kiser R., deGroot W. J., Holmes B., Kiker R., Viser G. A controlled study of the effects of single doses of hydrocortisone on the resolution of acute attacks of asthma. Am J Med. 1976 Jan;60(1):52–59. doi: 10.1016/0002-9343(76)90533-7. [DOI] [PubMed] [Google Scholar]
  85. Menitove S. M., Goldring R. M. Combined ventilator and bicarbonate strategy in the management of status asthmaticus. Am J Med. 1983 May;74(5):898–901. doi: 10.1016/0002-9343(83)91082-3. [DOI] [PubMed] [Google Scholar]
  86. Morell F., Orriols R., de Gracia J., Curull V., Pujol A. Controlled trial of intravenous corticosteroids in severe acute asthma. Thorax. 1992 Aug;47(8):588–591. doi: 10.1136/thx.47.8.588. [DOI] [PMC free article] [PubMed] [Google Scholar]
  87. Morgan M. D., Singh B. V., Frame M. H., Williams S. J. Terbutaline aerosol given through pear spacer in acute severe asthma. Br Med J (Clin Res Ed) 1982 Sep 25;285(6345):849–850. doi: 10.1136/bmj.285.6345.849. [DOI] [PMC free article] [PubMed] [Google Scholar]
  88. Morley T. F., Marozsan E., Zappasodi S. J., Gordon R., Griesback R., Giudice J. C. Comparison of beta-adrenergic agents delivered by nebulizer vs metered dose inhaler with InspirEase in hospitalized asthmatic patients. Chest. 1988 Dec;94(6):1205–1210. doi: 10.1378/chest.94.6.1205. [DOI] [PubMed] [Google Scholar]
  89. Murphy D. G., McDermott M. F., Rydman R. J., Sloan E. P., Zalenski R. J. Aminophylline in the treatment of acute asthma when beta 2-adrenergics and steroids are provided. Arch Intern Med. 1993 Aug 9;153(15):1784–1788. [PubMed] [Google Scholar]
  90. Newhouse M. T. Emergency department management of life-threatening asthma. Are nebulizers obsolete? Chest. 1993 Mar;103(3):661–663. doi: 10.1378/chest.103.3.661. [DOI] [PubMed] [Google Scholar]
  91. Newhouse M., Dolovich M. Aerosol therapy: nebulizer vs metered dose inhaler. Chest. 1987 Jun;91(6):799–800. doi: 10.1378/chest.91.6.799. [DOI] [PubMed] [Google Scholar]
  92. Nowak R. M., Gordon K. R., Wroblewski D. A., Tomlanovich M. C., Kvale P. A. Spirometric evaluation of acute bronchial asthma. JACEP. 1979 Jan;8(1):9–12. doi: 10.1016/s0361-1124(79)80439-6. [DOI] [PubMed] [Google Scholar]
  93. Nowak R. M., Pensler M. I., Sarkar D. D., Anderson J. A., Kvale P. A., Ortiz A. E., Tomlanovich M. C. Comparison of peak expiratory flow and FEV1 admission criteria for acute bronchial asthma. Ann Emerg Med. 1982 Feb;11(2):64–69. doi: 10.1016/s0196-0644(82)80298-9. [DOI] [PubMed] [Google Scholar]
  94. O'Driscoll B. R., Kalra S., Wilson M., Pickering C. A., Carroll K. B., Woodcock A. A. Double-blind trial of steroid tapering in acute asthma. Lancet. 1993 Feb 6;341(8841):324–327. doi: 10.1016/0140-6736(93)90134-3. [DOI] [PubMed] [Google Scholar]
  95. O'Driscoll B. R., Taylor R. J., Horsley M. G., Chambers D. K., Bernstein A. Nebulised salbutamol with and without ipratropium bromide in acute airflow obstruction. Lancet. 1989 Jun 24;1(8652):1418–1420. doi: 10.1016/s0140-6736(89)90126-8. [DOI] [PubMed] [Google Scholar]
  96. O'Rourke P. P., Crone R. K. Halothane in status asthmaticus. Crit Care Med. 1982 May;10(5):341–343. doi: 10.1097/00003246-198205000-00013. [DOI] [PubMed] [Google Scholar]
  98. Papo M. C., Frank J., Thompson A. E. A prospective, randomized study of continuous versus intermittent nebulized albuterol for severe status asthmaticus in children. Crit Care Med. 1993 Oct;21(10):1479–1486. doi: 10.1097/00003246-199310000-00015. [DOI] [PubMed] [Google Scholar]
  99. Raimondi A. C., Figueroa-Casas J. C., Roncoroni A. J. Comparison between high and moderate doses of hydrocortisone in the treatment of status asthmaticus. Chest. 1986 Jun;89(6):832–835. doi: 10.1378/chest.89.6.832. [DOI] [PubMed] [Google Scholar]
  100. Ratto D., Alfaro C., Sipsey J., Glovsky M. M., Sharma O. P. Are intravenous corticosteroids required in status asthmaticus? JAMA. 1988 Jul 22;260(4):527–529. [PubMed] [Google Scholar]
  101. Rea H. H., Scragg R., Jackson R., Beaglehole R., Fenwick J., Sutherland D. C. A case-control study of deaths from asthma. Thorax. 1986 Nov;41(11):833–839. doi: 10.1136/thx.41.11.833. [DOI] [PMC free article] [PubMed] [Google Scholar]
  102. Rebuck A. S., Chapman K. R., Abboud R., Pare P. D., Kreisman H., Wolkove N., Vickerson F. Nebulized anticholinergic and sympathomimetic treatment of asthma and chronic obstructive airways disease in the emergency room. Am J Med. 1987 Jan;82(1):59–64. doi: 10.1016/0002-9343(87)90378-0. [DOI] [PubMed] [Google Scholar]
  103. Reed S., Diggle S., Cushley M. J., Sleet R. A., Tattersfield A. E. Assessment and management of asthma in an accident and emergency department. Thorax. 1985 Dec;40(12):897–902. doi: 10.1136/thx.40.12.897. [DOI] [PMC free article] [PubMed] [Google Scholar]
  104. Robertson C. E., Steedman D., Sinclair C. J., Brown D., Malcolm-Smith N. Use of ether in life-threatening acute severe asthma. Lancet. 1985 Jan 26;1(8422):187–188. doi: 10.1016/s0140-6736(85)92025-2. [DOI] [PubMed] [Google Scholar]
  105. Robertson C. F., Smith F., Beck R., Levison H. Response to frequent low doses of nebulized salbutamol in acute asthma. J Pediatr. 1985 Apr;106(4):672–674. doi: 10.1016/s0022-3476(85)80101-3. [DOI] [PubMed] [Google Scholar]
  106. Robin E. D. Death from bronchial asthma. Chest. 1988 Mar;93(3):614–618. doi: 10.1378/chest.93.3.614. [DOI] [PubMed] [Google Scholar]
  107. Rock M. J., Reyes de la Rocha S., L'Hommedieu C. S., Truemper E. Use of ketamine in asthmatic children to treat respiratory failure refractory to conventional therapy. Crit Care Med. 1986 May;14(5):514–516. doi: 10.1097/00003246-198605000-00019. [DOI] [PubMed] [Google Scholar]
  108. Rossing T. H., Fanta C. H., Goldstein D. H., Snapper J. R., McFadden E. R., Jr Emergency therapy of asthma: comparison of the acute effects of parenteral and inhaled sympathomimetics and infused aminophylline. Am Rev Respir Dis. 1980 Sep;122(3):365–371. doi: 10.1164/arrd.1980.122.3.365. [DOI] [PubMed] [Google Scholar]
  109. Rossing T. H., Fanta C. H., McFadden E. R., Jr Effect of outpatient treatment of asthma with beta agonists on the response to sympathomimetics in an emergency room. Am J Med. 1983 Nov;75(5):781–784. doi: 10.1016/0002-9343(83)90407-2. [DOI] [PubMed] [Google Scholar]
  110. Rowe B. H., Keller J. L., Oxman A. D. Effectiveness of steroid therapy in acute exacerbations of asthma: a meta-analysis. Am J Emerg Med. 1992 Jul;10(4):301–310. doi: 10.1016/0735-6757(92)90007-k. [DOI] [PubMed] [Google Scholar]
  111. Ruffin R., Bryant D., Burdon J., Marlin G., Mitchell C., O'Hehir R., Wilson J., Woolcock A., Webb S. Comparison of the effects of nebulized terbutaline with intravenous enprofylline in patients with acute asthma. Chest. 1988 Mar;93(3):510–514. doi: 10.1378/chest.93.3.510. [DOI] [PubMed] [Google Scholar]
  112. Salmeron S., Brochard L., Mal H., Tenaillon A., Henry-Amar M., Renon D., Duroux P., Simonneau G. Nebulized versus intravenous albuterol in hypercapnic acute asthma. A multicenter, double-blind, randomized study. Am J Respir Crit Care Med. 1994 Jun;149(6):1466–1470. doi: 10.1164/ajrccm.149.6.8004299. [DOI] [PubMed] [Google Scholar]
  113. Salmeron S., Guerin J. C., Godard P., Renon D., Henry-Amar M., Duroux P., Taytard A. High doses of inhaled corticosteroids in unstable chronic asthma. A multicenter, double-blind, placebo-controlled study. Am Rev Respir Dis. 1989 Jul;140(1):167–171. doi: 10.1164/ajrccm/140.1.167. [DOI] [PubMed] [Google Scholar]
  114. Salzman G. A., Steele M. T., Pribble J. P., Elenbaas R. M., Pyszczynski D. R. Aerosolized metaproterenol in the treatment of asthmatics with severe airflow obstruction. Comparison of two delivery methods. Chest. 1989 May;95(5):1017–1020. doi: 10.1378/chest.95.5.1017. [DOI] [PubMed] [Google Scholar]
  115. Sarma V. J. Use of ketamine in acute severe asthma. Acta Anaesthesiol Scand. 1992 Jan;36(1):106–107. doi: 10.1111/j.1399-6576.1992.tb03432.x. [DOI] [PubMed] [Google Scholar]
  116. Saulnier F. F., Durocher A. V., Deturck R. A., Lefèbvre M. C., Wattel F. E. Respiratory and hemodynamic effects of halothane in status asthmaticus. Intensive Care Med. 1990;16(2):104–107. doi: 10.1007/BF02575303. [DOI] [PubMed] [Google Scholar]
  117. Schneider S. M., Pipher A., Britton H. L., Borok Z., Harcup C. H. High-dose methylprednisolone as initial therapy in patients with acute bronchospasm. J Asthma. 1988;25(4):189–193. doi: 10.3109/02770908809071365. [DOI] [PubMed] [Google Scholar]
  118. Schwartz S. H. Treatment of status asthmaticus with halothane. JAMA. 1984 May 25;251(20):2688–2689. [PubMed] [Google Scholar]
  119. Self T. H., Abou-Shala N., Burns R., Stewart C. F., Ellis R. F., Tsiu S. J., Kellermann A. L. Inhaled albuterol and oral prednisone therapy in hospitalized adult asthmatics. Does aminophylline add any benefit? Chest. 1990 Dec;98(6):1317–1321. doi: 10.1378/chest.98.6.1317. [DOI] [PubMed] [Google Scholar]
  120. Siegel D., Sheppard D., Gelb A., Weinberg P. F. Aminophylline increases the toxicity but not the efficacy of an inhaled beta-adrenergic agonist in the treatment of acute exacerbations of asthma. Am Rev Respir Dis. 1985 Aug;132(2):283–286. doi: 10.1164/arrd.1985.132.2.283. [DOI] [PubMed] [Google Scholar]
  121. Spitzer W. O., Suissa S., Ernst P., Horwitz R. I., Habbick B., Cockcroft D., Boivin J. F., McNutt M., Buist A. S., Rebuck A. S. The use of beta-agonists and the risk of death and near death from asthma. N Engl J Med. 1992 Feb 20;326(8):501–506. doi: 10.1056/NEJM199202203260801. [DOI] [PubMed] [Google Scholar]
  122. Stein L. M., Cole R. P. Early administration of corticosteroids in emergency room treatment of acute asthma. Ann Intern Med. 1990 Jun 1;112(11):822–827. doi: 10.7326/0003-4819-112-11-822. [DOI] [PubMed] [Google Scholar]
  123. Strube P. J., Hallam P. L. Ketamine by continuous infusion in status asthmaticus. Anaesthesia. 1986 Oct;41(10):1017–1019. doi: 10.1111/j.1365-2044.1986.tb12744.x. [DOI] [PubMed] [Google Scholar]
  124. Summer W., Elston R., Tharpe L., Nelson S., Haponik E. F. Aerosol bronchodilator delivery methods. Relative impact on pulmonary function and cost of respiratory care. Arch Intern Med. 1989 Mar;149(3):618–623. doi: 10.1001/archinte.149.3.618. [DOI] [PubMed] [Google Scholar]
  125. Summers Q. A., Tarala R. A. Nebulized ipratropium in the treatment of acute asthma. Chest. 1990 Feb;97(2):425–429. doi: 10.1378/chest.97.2.425. [DOI] [PubMed] [Google Scholar]
  126. Tanaka R. M., Santiago S. M., Kuhn G. J., Williams R. E., Klaustermeyer W. B. Intravenous methylprednisolone in adults in status asthmaticus. Comparison of two dosages. Chest. 1982 Oct;82(4):438–440. doi: 10.1378/chest.82.4.438. [DOI] [PubMed] [Google Scholar]
  127. Tarala R. A., Madsen B. W., Paterson J. W. Comparative efficacy of salbutamol by pressurized aerosol and wet nebulizer in acute asthma. Br J Clin Pharmacol. 1980 Oct;10(4):393–397. doi: 10.1111/j.1365-2125.1980.tb01776.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  128. Taylor D. R., Sears M. R., Herbison G. P., Flannery E. M., Print C. G., Lake D. C., Yates D. M., Lucas M. K., Li Q. Regular inhaled beta agonist in asthma: effects on exacerbations and lung function. Thorax. 1993 Feb;48(2):134–138. doi: 10.1136/thx.48.2.134. [DOI] [PMC free article] [PubMed] [Google Scholar]
  129. Thompson J. D., Fish S., Ruiz E. Succinylcholine for endotracheal intubation. Ann Emerg Med. 1982 Oct;11(10):526–529. doi: 10.1016/s0196-0644(82)80423-x. [DOI] [PubMed] [Google Scholar]
  130. Turner J. R., Corkery K. J., Eckman D., Gelb A. M., Lipavsky A., Sheppard D. Equivalence of continuous flow nebulizer and metered-dose inhaler with reservoir bag for treatment of acute airflow obstruction. Chest. 1988 Mar;93(3):476–481. doi: 10.1378/chest.93.3.476. [DOI] [PubMed] [Google Scholar]
  131. Ward M. J., Fentem P. H., Smith W. H., Davies D. Ipratropium bromide in acute asthma. Br Med J (Clin Res Ed) 1981 Feb 21;282(6264):598–600. doi: 10.1136/bmj.282.6264.598. [DOI] [PMC free article] [PubMed] [Google Scholar]
  132. Webb J. R. Dose response of patients to oral corticosteroid treatment during exacerbations of asthma. Br Med J (Clin Res Ed) 1986 Apr 19;292(6527):1045–1047. doi: 10.1136/bmj.292.6527.1045. [DOI] [PMC free article] [PubMed] [Google Scholar]
  133. Westerman D. E., Benatar S. R., Potgieter P. D., Ferguson A. D. Identification of the high-risk asthmatic patient. Experience with 39 patients undergoing ventilation for status asthmaticus. Am J Med. 1979 Apr;66(4):565–572. doi: 10.1016/0002-9343(79)91165-3. [DOI] [PubMed] [Google Scholar]
  134. White P. F., Way W. L., Trevor A. J. Ketamine--its pharmacology and therapeutic uses. Anesthesiology. 1982 Feb;56(2):119–136. doi: 10.1097/00000542-198202000-00007. [DOI] [PubMed] [Google Scholar]
  135. Whyte K. F., Gould G. A., Jeffrey A. A., Airlie M. A., Flenley D. C., Douglas N. J. Dose of nebulized ipratropium bromide in acute severe asthma. Respir Med. 1991 Nov;85(6):517–520. doi: 10.1016/s0954-6111(06)80270-2. [DOI] [PubMed] [Google Scholar]
  136. Wilkins K., Mao Y. Trends in rates of admission to hospital and death from asthma among children and young adults in Canada during the 1980s. CMAJ. 1993 Jan 15;148(2):185–190. [PMC free article] [PubMed] [Google Scholar]
  137. Williams S. J., Parrish R. W., Seaton A. Comparison of intravenous aminophylline and salbutamol in severe asthma. Br Med J. 1975 Dec 20;4(5998):685–685. doi: 10.1136/bmj.4.5998.685. [DOI] [PMC free article] [PubMed] [Google Scholar]
  138. Williams S. J., Winner S. J., Clark T. J. Comparison of inhaled and intravenous terbutaline in acute severe asthma. Thorax. 1981 Aug;36(8):629–631. doi: 10.1136/thx.36.8.629. [DOI] [PMC free article] [PubMed] [Google Scholar]
  139. Williams S., Seaton A. Intravenous or inhaled salbutamol in severe acute asthma? Thorax. 1977 Oct;32(5):555–558. doi: 10.1136/thx.32.5.555. [DOI] [PMC free article] [PubMed] [Google Scholar]
  140. Woolcock A., Rubinfeld A. R., Seale J. P., Landau L. L., Antic R., Mitchell C., Rea H. H., Zimmerman P. Thoracic society of Australia and New Zealand. Asthma management plan, 1989. Med J Aust. 1989 Dec 4;151(11-12):650–653. [PubMed] [Google Scholar]
  141. Worthington J. R., Ahuja J. The value of pulmonary function tests in the management of acute asthma. CMAJ. 1989 Jan 15;140(2):153–156. [PMC free article] [PubMed] [Google Scholar]
  142. Wrenn K., Slovis C. M., Murphy F., Greenberg R. S. Aminophylline therapy for acute bronchospastic disease in the emergency room. Ann Intern Med. 1991 Aug 15;115(4):241–247. doi: 10.7326/0003-4819-115-4-241. [DOI] [PubMed] [Google Scholar]
  143. Zainudin B. M., Ismail O., Yusoff K. Effect of adding aminophylline infusion to nebulised salbutamol in severe acute asthma. Thorax. 1994 Mar;49(3):267–269. doi: 10.1136/thx.49.3.267. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from CMAJ: Canadian Medical Association Journal are provided here courtesy of Canadian Medical Association

RESOURCES